We’re proud to be featured in Applied Clinical Trials’ latest article spotlighting the future of pharmacovigilance: “Harnessing Technology and Adopting Unified Approaches to Optimize Pharmacovigilance Activities.”
In this thought leadership piece, our VP of Product, Daniel O’keeffe, explores how unified, digital-first approaches are reshaping global PV – putting patient safety front and center while reducing complexity and cost.
From persona based, fully configurable, digital tools, to AI-powered document ingestion, discover how Qinecsa ticks all the boxes for modern pharmacovigilance intake
